Jammu, India

Kamal Kishore Kapoor



 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kamal Kishore Kapoor: Innovator in Kynurenine Pathway Research

Introduction

Kamal Kishore Kapoor is a notable inventor based in Jammu, India. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors targeting the kynurenine pathway. With a total of four patents to his name, Kapoor's work is paving the way for new therapeutic approaches.

Latest Patents

Kamal Kishore Kapoor's latest patents focus on novel inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2, and tryptophan 2,3-dioxygenase. These compounds, along with their metabolites and pharmaceutically acceptable salts or prodrugs, are designed to treat diseases resulting from dysregulation of the kynurenine pathway. The compounds act by inhibiting the enzymatic activity or expression of the aforementioned enzymes, providing a promising avenue for therapeutic intervention.

Career Highlights

Throughout his career, Kapoor has worked with reputable companies such as Curadev Pharma Pvt Ltd and Sphaera Pharma Pte. Ltd. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Kamal Kishore Kapoor has collaborated with notable professionals in his field, including Monali Banerjee and Sandip Middya. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kamal Kishore Kapoor is a distinguished inventor whose work on kynurenine pathway inhibitors holds great potential for treating various diseases. His contributions to biochemistry and drug development are noteworthy and continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…